Opportunities: UroGen Pharma Ltd (URGN) Stock in the Short-Term and the Long-Term
Jefferies lowered the price target for the UroGen Pharma Ltd (NASDAQ:URGN) stock from “a Buy” to “a Hold”. The rating was released on February 08, 2023, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $57. The stock was reiterated by H.C. Wainwright, […]
Invest in UroGen Pharma Ltd (URGN) Stock with the prospect of future returns
Jefferies lowered the price target for the UroGen Pharma Ltd (NASDAQ:URGN) stock from “a Buy” to “a Hold”. The rating was released on February 08, 2023, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $57. The stock was reiterated by H.C. Wainwright, […]
UroGen Pharma Ltd (NASDAQ:URGN) stock Reported Profit Margin of -123.61 percent in Last Year: Is Defensible?
Jefferies lowered the price target for the UroGen Pharma Ltd (NASDAQ:URGN) stock from “a Buy” to “a Hold”. The rating was released on February 08, 2023, according to finviz. The research report from H.C. Wainwright has reiterated the stock to Buy, with a price target set at $57. The stock was reiterated by H.C. Wainwright, […]
